Rchr
J-GLOBAL ID:200901052583820378   Update date: Nov. 12, 2024

NISHIMURA Ken

ニシムラ ケン | NISHIMURA Ken
Affiliation and department:
Job title: Professor
Research field  (1): Medical biochemistry
Research keywords  (1): Stem cell biotechnology, Gene regulation
Research theme for competitive and other funds  (19):
  • 2023 - 2026 Cell fate decision by dose of transcription factors
  • 2022 - 2024 複数・大量タンパク導入システムを用いたスーパーエクソソームによる肝再生療法開発
  • 2021 - 2024 Mechanistic analysis of somatic cell reprogramming using paused iPSCs
  • 2019 - 2022 Molecular dynamics of epigenomic transcriptional regulation by Klf4 in iPSC generation
  • 2019 - 2021 Safe and efficient selection of differentiated cells by stage-specific gene expression from auto-erasable vector
Show all
Papers (69):
  • Jingwen Zhou, Yuya Sekiguchi, Masayuki Sano, Ken Nishimura, Koji Hisatake, Aya Fukuda. A Sendai virus-based expression system directs efficient induction of chondrocytes by transcription factor-mediated reprogramming. Scientific reports. 2024. 14. 1. 26004-26004
  • Utsugi, Yuki, Nishimura, Ken, Yamanaka, Satoshi, Nishino, Kohei, Kosako, Hidetaka, Sawasaki, Tatsuya, Shigemori, Hideyuki, Wandless, Thomas J, Miyamae, Yusaku. Ubiquitin-Derived Fragment as a Peptide Linker for the Efficient Cleavage of a Target Protein from a Degron. ACS CHEMICAL BIOLOGY. 2024. 19. 2. 497-505
  • Takumi Kishimoto, Ken Nishimura, Kana Morishita, Aya Fukuda, Yusaku Miyamae, Yutaro Kumagai, Kimio Sumaru, Mahito Nakanishi, Koji Hisatake, Masayuki Sano. An engineered ligand-responsive Csy4 endoribonuclease controls transgene expression from Sendai virus vectors. Journal of biological engineering. 2024. 18. 1. 9-9
  • Takeda, Nobutaka, Tsuchiya, Atsunori, Mito, Masaki, Natsui, Kazuki, Natusi, Yui, Koseki, Yohei, Tomiyoshi, Kei, Yamazaki, Fusako, Yoshida, Yuki, Abe, Hiroyuki, et al. Analysis of distribution, collection, and confirmation of capacity dependency of small extracellular vesicles toward a therapy for liver cirrhosis. INFLAMMATION AND REGENERATION. 2023. 43. 1
  • Sekiguchi, Yuya, Fukuda, Aya, Nishimura, Ken, Hisatake, Koji. Engineering Critical Residues of SOX9 Discovers a Variant With Potent Capacity to Induce Chondrocytes. STEM CELLS. 2023. Epub
more...
MISC (3):
  • Ken Nishimura, Hiroaki Segawa, Mahito Nakanishi. Development of novel defective sendai virus vectors capable of expressing therapeutic genes persistently. JOURNAL OF GENE MEDICINE. 2008. 10. 4. 444-444
  • Ken Nishimura, Hiroaki Segawa, Takahiro Goto, Mariko Morishita, Takemasa Sakaguchi, Tetsuya Yoshida, Kozo Takayama, Mahito Nakanishi. Persistent gene expression from a novel RNA virus vector based on Sendai virus cl.151 STRAIN. JOURNAL OF GENE MEDICINE. 2006. 8. 12. 1457-1457
  • Takahiro Goto, Mariko Morishita, Ken Nishimura, Mahito Nakanishi, Atsushi Kato, Jumpei Ehara, Kozo Takayama. Novel mucosal insulin delivery systems based on fusogenic liposomes. Pharmaceutical research. 2006. 23. 2. 384-91
Patents (7):
  • 末梢血単球由来多能性幹細胞作製方法
  • 末梢血単球由来多能性幹細胞作製方法
  • 多能性幹細胞作製用ベクター材料及びこれを用いた多能性幹細胞作製方法
  • 多能性幹細胞作製用ベクター材料及びこれを用いた多能性幹細胞作製方法
  • 改良された持続感染型センダイウイルスベクター
more...
Lectures and oral presentations  (63):
  • Discovery of a novel SOX9 mutant with potent capacity to induce chondrocytes
    (The 36th Annual Meeting of the Japanese Society of Cartilage Metabolism)
  • 切除可能なデグロンを用いた細胞内標的タンパク質発現制御手法の開発
    (日本農芸化学会関東支部2023年度大会)
  • 切除可能なデグロンを用いた細胞内標的タンパク質発現制御手法の開発
    (日本ケミカルバイオロジー 学会第17回年会)
  • Mechanistic analysis of chromosome-wide epigenetic change during iPSC generation using Klf4-dose dependent reprogramming system
    (The 20th International Joint Mini-Symposium on Molecular and Cell Biology among KU-NTU-UT)
  • iPS細胞誘導過程において二相性の機能を有するE2F4の解析
    (第45回日本分子生物学会年会)
more...
Work history (1):
  • 2017/08 - 現在 国立大学法人筑波大学 医学医療系 准教授
Awards (1):
  • 2018/04 - 産業技術総合研究所 産業技術総合研究所 平成29年度理事長賞(研究)
Association Membership(s) (2):
THE JAPANESE SOCIETY FOR REGENERATIVE MEDICINE ,  The Molecular Biology Society of Japan
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page